» Articles » PMID: 22983455

Omentum-preserving Gastrectomy for Advanced Gastric Cancer: a Propensity-matched Retrospective Cohort Study

Overview
Journal Gastric Cancer
Date 2012 Sep 18
PMID 22983455
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Objectives: We clarified the impact of omentectomy for advanced gastric cancer on patient survival from the surgical results of a high-volume center in Japan.

Methods: Patients who received curative gastrectomy were divided into two groups based on whether they underwent omentectomy. The propensity score-matching method was used to assemble a well-balanced cohort, and relapse-free survival and the pattern of recurrence were compared.

Results: For this study, 330 patients who fulfilled the inclusion criteria participated and were divided into two groups: group R, patients who received omentectomy, and group P, patients who received omentum-preserving gastrectomy. After performing score-matching, 196 patients were selected. The 3- and 5-year relapse-free survival rates were 72.9% (95% confidence interval, 64.1-81.7) and 66.2% (56.6-75.8%) in group R, and 76.7% (67.9-81.2) and 67.3% (55.1-79.5) in group P, which were not significantly different (P = 0.750). Regarding sites of relapses, no differences were observed between the groups (P = 0.863).

Conclusions: In this series, omentum-preserving gastrectomy for advanced gastric cancer did not increase the peritoneal relapse rate or affect patient survival compared to conventional gastrectomy. The non-inferiority of the omission of omentectomy should be evaluated by a randomized controlled trial.

Citing Articles

Korean Practice Guidelines for Gastric Cancer 2024: An Evidence-based, Multidisciplinary Approach (Update of 2022 Guideline).

Kim I, Kang S, Choi W, Seo A, Eom B, Kang B J Gastric Cancer. 2025; 25(1):5-114.

PMID: 39822170 PMC: 11739648. DOI: 10.5230/jgc.2025.25.e11.


National validation of laparoscopic approach for locally advanced gastric cancer: Comparison of a randomized controlled trial and real-world practice results.

Eom B, Han M, Yoon H, Hyung W, Yang H, Park Y Chin J Cancer Res. 2025; 36(6):742-751.

PMID: 39802891 PMC: 11724173. DOI: 10.21147/j.issn.1000-9604.2024.06.11.


Effect of omentum preservation on long-term prognosis of locally advanced gastric cancer: a systematic review and meta-analysis.

Zhou X, Sheng W, Huang T, Ren W World J Surg Oncol. 2024; 22(1):236.

PMID: 39243034 PMC: 11378409. DOI: 10.1186/s12957-024-03521-3.


Omentum preservation versus complete omentectomy in gastrectomy for gastric cancer (OMEGA trial): study protocol for a randomized controlled trial.

Keywani K, Eshuis W, Borgstein A, van Det M, van Duijvendijk P, van Etten B Trials. 2024; 25(1):588.

PMID: 39232781 PMC: 11375919. DOI: 10.1186/s13063-024-08396-z.


Gastric Cancer Surgery: Balancing Oncological Efficacy against Postoperative Morbidity and Function Detriment.

Tsekrekos A, Okumura Y, Rouvelas I, Nilsson M Cancers (Basel). 2024; 16(9).

PMID: 38730693 PMC: 11083646. DOI: 10.3390/cancers16091741.


References
1.
. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011; 14(2):113-23. DOI: 10.1007/s10120-011-0042-4. View

2.
Hagiwara A, Takahashi T, Sawai K, Taniguchi H, Shimotsuma M, Okano S . Milky spots as the implantation site for malignant cells in peritoneal dissemination in mice. Cancer Res. 1993; 53(3):687-92. View

3.
Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A . Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007; 357(18):1810-20. DOI: 10.1056/NEJMoa072252. View

4.
Lawrance R, Loizidou M, Cooper A, Alexander P, Taylor I . Importance of the omentum in the development of intra-abdominal metastases. Br J Surg. 1991; 78(1):117-9. DOI: 10.1002/bjs.1800780135. View

5.
Imada T, Matsumoto A . [Mechanism by which peritoneal disseminated metastasis develops in gastric cancer]. Nihon Geka Gakkai Zasshi. 1986; 87(6):593-603. View